Snowball logo
logo
KYMR_logo

Kymera Therapeutics, Inc

KYMR β€’ NASDAQ
$114.42+$0.39Β  (0.34%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
72.8346.8378.5947.0739.2105
COGS
2.3972.977189.17.373--
Gross Profit
72.8346.8378.5947.0739.2107.1
Operating Expenses & Income
Operating Income
(100.5)(161.3)(165.5)(261.6)(349.4)(350.2)
Total Operating Expenses
173.4208.1244.1308.7388.6457.3
R&D Expenses
137164.2189.1240.2316.6375.6
Selling General & Admin Expenses
36.3443.8355.0463.5368.275.77
Earnings from Continuing Operations
Interest Expense
(0.175)(0.176)(0.196)(0.249)(0.249)(0.309)
Interest Income
0.4886.62418.7638.0338.4236.43
Income Tax Expense
(2.222)(2.977)18.76---
Net Income
Net Income
(100.2)(154.8)(147)(223.9)(311.4)(299.6)
Supplemental
EBIT
(100)(154.6)(146.8)(223.6)(311.4)-
EBITDA
(97.64)(151.7)(143.2)(216.2)(303.1)(292.8)
In millions of USD, except % and values per 1 share